Epidemiological analysis of Parkinson's disease in Krasnodar
https://doi.org/10.51793/OS.2025.28.4.007
Abstract
Background. Parkinson's disease, a chronic progressive disease of the central nervous system, is the second most common neurodegenerative disease. Life expectancy has been steadily increasing in recent decades, therefore, the number of patients with Parkinson's disease will increase sharply in the coming decades both throughout the world and in Russia. Epidemiological data of Parkinson's disease are variable throughout the world and within one country. The results of studies of epidemiological indicators of Parkinson's disease in Russia differ significantly depending on the region where they were conducted, which may be due to the demographic characteristics of populations, migration processes, environmental influences, and differences in the organization of the healthcare system. The purpose of the study is to study the main epidemiological indicators for Parkinson's disease in Krasnodar, as well as the structure of some clinical characteristics.
Results. A retrospective analysis was carried out with subsequent statistical processing of 693 outpatient records of patients with Parkinson's disease for 2021, who were under observation in the office of extrapyramidal disorders of the State Budgetary Healthcare Institution of the SBHI RCH named after Professor S.V. Ochapovsky for the period from 2013 to 2021, included in the database of the unified register of patients with Parkinson's disease in the territory of Krasnodar. The obtained data were processed by the method of variation statistics using a personal computer and statistical programs Statistica 10 and Microsoft Office Excel 2007. Prevalence of Parkinson's disease in Krasnodar is above the national average. The ratio between men and women is not statistically significant. The highest prevalence rate is in the age group from 60 to 80 years. The mixed (akinetic-rigid-tremorous) form, stage 3 of the disease, predominates in the population, moderate rate of progression.
Conclusion. The data obtained can be used to expand the information in a unified database, identify existing problems at the diagnostic and treatment stage, which will improve the quality and life expectancy of patients.
About the Author
E. Yu. Efimenko
Kuban State Medical University
Россия
Россия
Ekaterina Yu. Efimenko - full-time postgraduate student of the Department of Nervous Diseases and Neurosurgery with a course of Nervous Diseases and Neurosurgery of the Faculty of Advanced Training and Professional Retraining of Specialists, Federal State Budgetary Educational Institution of Higher Education Kuban State Medical University of the Ministry of Health of the Russian Federation.
4 Mitrofana Sedina St., Krasnodar, 350063
References
1. Levin O. S., Fedorova N. V. Parkinson's disease. Moscow: MEDpress-inform, 2012. 352 р. (In Russ.)
2. Goncharova Z. A., Rabadanova E. A., Gel'pei M. A. Epidemiology analysis of Parkinson's disease in Rostov-on-Don. Saratovskii nauchno-meditsinskii zhurnal. 2017; 13 (1): 135-139. (In Russ.)
3. Levin O. S., Artemyev D. V., Bril E. V., Kulua T. K. Parkinson's disease: current approaches to diagnosis and treatment. Prakticheskaya meditsina. 2017; 1 (102): 45-51. (In Russ.)
4. Kulua T. K., Fedorova N. V., Bril E. V. Quality of life in patients with Parkinson's disease. Farmateka. 2017; 20 (353): 13-18. (In Russ.)
5. Illarioshkin S. N., Levin O. S. Parkinson's Disease Diagnosis and Treatment Guide. Moscow: IPK Pareto-Print, 2019. 336 р. (In Russ.)
6. Katunina E. A., Bezdol'nyi Yu. N. Epidemiology of Parkinson's Disease. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova. 2013; 113 (12): 81-88. (In Russ.)
7. Bajramukova A. M., Azhahmetova A. K., Karpov S. M. Epidemiologiya bolezni Parkinsona v razlichnyh stranah mira. Uspekhi sovremennogo estestvoznaniya. 2013; (9): 20-21. (In Russ.)
8. Katunina E. A., Bezdol'nyi Yu. N. Epidemiological studies of parkinsonism: guidelines. Moscow: Pirogov Russian National Research Medical University, 2010. 24 р. (In Russ.)
9. Dorsey E. R., Constantinescu R., Thompson J. P., Biglan K. M., Holloway R. G., Kieburtz K., Marshall F. J., Ravina B. M., Schifitto G., Siderowf A., Tanner C. M. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007; 68: 384-386. DOI: 10.1212/01.wnl.0000247740.47667.03.
10. Marras C., Beck J. C., Bower J. H., Roberts E., Ritz B., Ross G. W., et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinsons Dis. 2018; 4: 21. DOI: 10.1038/s41531-018-0058-0.
11. Venkataraman V., Donohue S. J., Biglan K. M., Wicks P., Dorsey E. R. Virtual visits for Parkinson disease: A case series. Neurol Clin Pract. 2014; 4 (2): 146-152. DOI: 10.1212/01.CPJ.0000437937.63347.5a.
12. Krivonos O. V., Smolentseva I. G., Amosova N. A. Epidemiological monitoring of the incidence of Parkinson's disease. Saratovskii nauchno-meditsinskii zhurnal. 2013; 9 (4): 873-877. (In Russ.)
13. Rozhdestvensky A. S., Delov R. A., Marks E. A., Gaponenko I. A., Khanokh E. V. Clinical and Epidemiological Aspects of Parkinson's Disease in the South of Western Siberia. Front Neurol. 2020; 3 (11): 538782. DOI: 10.3389/fneur.2020.538782.
14. Wright Willis A., Evanoff B. A., Lian M., Criswell S. R., Racette B. A. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010; 34: 143-151. DOI: 10.1159/000275491.
15. Poletti M., Frosini D., Pagni C., Lucetti C., Del Dotto P., Tognoni G. The association between motor subtypes and alexithymia in de novo Parkinson's disease. J Neurol. 2011; 258: 1042-1045. DOI: 10.1007/s00415-010-5878-8.
16. Porter B., Macfarlane R., Unwin N., Walker R. The Prevalence of Parkinson’s Disease in an Area of North Tyneside in the North-East of England. Neuroepidemiology. 2006; 26: 156-161.
17. Pugacheva V. S., Karpov S. M., Vishlova I. A. Parkinson’s illness: Prevalence of the disease from the point of view of medical statistics. Bulleten nauki i praktiki. 2016; 5: 191-203. (In Russ.)
18. Benito-León J., Bermejo-Pareja F., Rodríguez J., Molina J. A., Gabriel R., Morales J. M. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord. 2003; 3 (18): 267-274.
19. Razdorskaya V. V., Voskresenkaya O. N., Yudina G. K. Parkinson's disease in Russia: prevalence and incidence. Saratovskii nauchno-meditsinskii zhurnal. 2016; 12 (3): 379-384. (In Russ.)
20. Katunina E. A., Bezdol'nyi Yu. N. Epidemiology of Parkinson's Disease. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova. 2013; 113 (12): 81-88. (In Russ.)
21. Stewart A., Factor W. J. Weiner Parkinson’s Disease. Diagnosis and Clinical Management. 2008; 819.
22. Yamawaki M., Kusumi M., Kowa H., Nakashima K. Changes in prevalence and incidence of Parkinson’s disease in Japan during a quarter of a century. Neuroepidemiology. 2009; 32: 263-269.
23. Venkataraman V., Donohue S. J., Biglan K. M., Wicks P., Dorsey E. R. Virtual visits for Parkinson disease: A case series. Neurol Clin Pract. 2014; 4 (2): 146-152. DOI: 10.1212/01.CPJ.0000437937.63347.5a.
24. Zhukova I. A., Zhukova N. G. Cognitive impairment in patients with Parkinson’s disease. Bulleten sibirskoi meditsiny. 2010; 4: 54-58. (In Russ.)
25. Rabadanova E. A., Gelpey M. A., Goncharova Z. A. Non-motor symptoms of Parkinson’s disease, their structure and influence on the quality of life of patients. Prakticheskaya meditsina. 2015; 5 (90): 111-115. (In Russ.)
26. Radyuk M. A., Svetozarsky S. N., Kopishinskaya S. V. Non-motor manifestations of Parkinson's disease. Meditsinskii almanakh. 2014; 3 (33): 54-58. (In Russ.)
27. Fedorova N. V., Omarova S. M. Levodopa-induced dyskinesias in Parkinson's disease: pharmacotherapy and surgical treatment. Nervnye bolezni. 2017; 1: 22-27. (In Russ.)
28. Sapronova M. R., Shnaider N. A. The epidemiological, clinical and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk). Neurology, Neuropsychiatry, Psychosomatics. 2014; 4: 59-88. (In Russ.) DOI: 10.14412/2074-2711-2014-4-59-64.
29. Khnova M. N., Madzhidova Yo. N. Tashkentskii pediatricheskii meditsinskii institut. Vestnik KazNMU. 2015; 2: 464-466. (In Russ.)
Review
For citations:
Efimenko E.Yu. Epidemiological analysis of Parkinson's disease in Krasnodar. Lechaschi Vrach. 2025;(4):49-53. (In Russ.) https://doi.org/10.51793/OS.2025.28.4.007
Views:
108
JATS XML
Email this article 
